Evidence map›Paper›PMID 23143685›Full record

ArticleEukaryotic cell2013

Improved gene ontology annotation for biofilm formation, filamentous growth, and phenotypic switching in Candida albicans.

Diane O Inglis, Marek S Skrzypek, Martha B Arnaud, Jonathan Binkley, Prachi Shah, Farrell Wymore, Gavin Sherlock

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Fungal morphogenesis.Cold Spring Harbor perspectives in medicine · 2014
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A guide to best practices for Gene Ontology (GO) manual annotation.Database : the journal of biological databases and curation · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Diane O InglisDepartment of Genetics, Stanford University Medical School, Stanford, California, USA.
Marek S Skrzypek
Martha B Arnaud
Jonathan Binkley
Prachi Shah
Farrell Wymore
Gavin Sherlock
Stanford University · US

Funding

Genomic Database for Candida AlbicansR01DE015873 · NIDCR · STANFORD UNIVERSITY · PI Gavin J Sherlock · 2004 to 2026
$11.7M
NIDCR NIH HHS R01 DE015873
6 · The paper itself

Abstract

The opportunistic fungal pathogen Candida albicans is a significant medical threat, especially for immunocompromised patients. Experimental research has focused on specific areas of C. albicans biology, with the goal of understanding the multiple factors that contribute to its pathogenic potential. Some of these factors include cell adhesion, invasive or filamentous growth, and the formation of drug-resistant biofilms. The Gene Ontology (GO) (www.geneontology.org) is a standardized vocabulary that the Candida Genome Database (CGD) (www.candidagenome.org) and other groups use to describe the functions of gene products. To improve the breadth and accuracy of pathogenicity-related gene product descriptions and to facilitate the description of as yet uncharacterized but potentially pathogenicity-related genes in Candida species, CGD undertook a three-part project: first, the addition of terms to the biological process branch of the GO to improve the description of fungus-related processes; second, manual recuration of gene product annotations in CGD to use the improved GO vocabulary; and third, computational ortholog-based transfer of GO annotations from experimentally characterized gene products, using these new terms, to uncharacterized orthologs in other Candida species. Through genome annotation and analysis, we identified candidate pathogenicity genes in seven non-C. albicans Candida species and in one additional C. albicans strain, WO-1. We also defined a set of C. albicans genes at the intersection of biofilm formation, filamentous growth, pathogenesis, and phenotypic switching of this opportunistic fungal pathogen, which provides a compelling list of candidates for further experimentation.

Indexed as

BiofilmsGenes, FungalMolecular Sequence AnnotationCandida albicansComputational BiologyHyphaeModels, GeneticPhenotypeVirulence

Identifiers

PMID23143685
PMCPMC3535841
OpenAlexW2139488778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.